Novare Capital Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.71M Buy
39,808
+1,194
+3% +$148K 0.37% 64
2025
Q4
$4.86M Sell
38,614
-49,119
-56% -$6.41M 0.36% 64
2025
Q3
$12.8M Sell
87,733
-8,438
-9% -$1.28M 0.98% 33
2025
Q2
$15M Buy
96,171
+501
+0.5% +$79.4K 1.22% 21
2025
Q1
$15.8M Buy
95,670
+48,667
+104% +$8.09M 1.38% 20
2024
Q4
$7.66M Sell
47,003
-1,883
-4% -$337K 0.64% 57
2024
Q3
$9.55M Sell
48,886
-1,000
-2% -$184K 0.81% 53
2024
Q2
$8.65M Buy
49,886
+469
+0.9% +$78K 0.78% 49
2024
Q1
$8.36M Buy
49,417
+2,014
+4% +$377K 0.76% 54
2023
Q4
$9.36M Buy
47,403
+2,130
+5% +$377K 0.95% 46
2023
Q3
$7.88M Sell
45,273
-870
-2% -$158K 0.89% 51
2023
Q2
$7.95M Sell
46,143
-605
-1% -$105K 0.85% 54
2023
Q1
$7.78M Sell
46,748
-241
-0.5% -$39.5K 0.88% 50
2022
Q4
$6.89M Sell
46,989
-109
-0.2% -$16.1K 0.81% 57
2022
Q3
$6.98M Buy
47,098
+1,004
+2% +$168K 0.89% 49
2022
Q2
$7.92M Sell
46,094
-966
-2% -$167K 0.98% 37
2022
Q1
$8.88M Sell
47,060
-587
-1% -$116K 0.95% 39
2021
Q4
$11.6M Sell
47,647
-519
-1% -$114K 1.18% 28
2021
Q3
$9.35M Sell
48,166
-1,709
-3% -$345K 1.04% 39
2021
Q2
$9.29M Buy
49,875
+1,592
+3% +$276K 1.04% 39
2021
Q1
$7.6M Buy
48,283
+4,240
+10% +$672K 0.92% 49
2020
Q4
$7.29M Buy
44,043
+426
+1% +$69.3K 0.95% 42
2020
Q3
$7.21M Buy
43,617
+1,913
+5% +$294K 1.02% 36
2020
Q2
$5.71M Buy
41,704
+5,519
+15% +$721K 0.85% 50
2020
Q1
$4.26M Buy
+36,185
New +$4.76M 0.75% 61

Other funds holding ZTS

Novare Capital Management's ZTS Position: Q1 2026 in Review

Novare Capital Management increased its Zoetis (ZTS) stake by 3.1% in Q1 2026, buying an estimated $148K and bringing the position to 39,808 shares worth $4.71M. The position accounts for 0.37% of the portfolio, ranked #64.

Novare Capital Management first reported a position in ZTS in Q1 2020 and has held it in 25 quarters since. The position peaked at $15.8M in Q1 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Novare Capital Management held 39,808 shares of Zoetis worth $4.71M as of Q1 2026.
  • Novare Capital Management bought 1,194 Zoetis shares in Q1 2026, an estimated $148K.
  • Zoetis made up 0.37% of Novare Capital Management's portfolio in Q1 2026, its #64 holding.
  • Novare Capital Management first reported a position in Zoetis in Q1 2020 and has held it in 25 quarters since.
  • Novare Capital Management's Zoetis position peaked at $15.8M in Q1 2025.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Novare Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.